**TABLE 87.1 Characteristics of Human Pathogenic Alphaviruses**

| Virus               | Epidemiology and Endemic Regions                                                                                                  | Occurrence and Number of Reported Cases                                                                                                                                                                                                     | Fever (%) | Rash (%) | Myalgia (%) | Arthralgia/arthritis (%) |
| :------------------ | :-------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | :-------- | :------- | :---------- | :----------------------- |
| Chikungunya         | Tropical and subtropical regions of Asia, Africa and Latin America                                                                | Large sporadic epidemics                                                                                                                                                                                                                    | 90        | 40-50    | 90          | >95                      |
| Sindbis Virus Group | Eurasia, Africa, Australia, Oceania; primarily reported from West Russia (“Karelian fever”), Finland (“Pogosta disease”), and Sweden (“Ockelbo disease”) | Geographically most widely distributed alphavirus (lack of data on human cases) Karelian fever: rare (no data) Pogosta disease: 140 cases (range 1-1282)/year Ockelbo disease: 30 cases/year                                                 | 15-40     | 90       | 50          | 95                       |
| Ross River          | Australia, Papua New Guinea, West Papua                                                                                           | 5000 cases per year in Australia; in 1979-1980 an epidemic with >60000 cases hit some pacific islands (New Caledonia, Fiji, Samoa, Cook Islands)                                                                                            | 20-60     | 40-60    | 40-80       | 80-100                   |
| Barmah Forest       | Australia                                                                                                                         | 2000 cases/year                                                                                                                                                                                                                             | 50        | 40-60    | 50-80       | 70-95                    |
| O’Nyong Nyong       | East Africa                                                                                                                       | Rare epidemics; >2 million cases in 1959-1961                                                                                                                                                                                               | 80-100    | 70-90    | 70          | 60-100                   |
| Mayaro              | South America, primarily the Amazonian rainforest, Caribbean                                                                      | Sporadic single cases and small outbreaks (involving 10-100 cases)                                                                                                                                                                          | 100       | 30-50    | 75          | 50-90                    |

Adapted from Suhrbier, A., Jaffar-Bandjee, M.C., Gasque, P., 2012. Arthritogenic alphaviruses-an overview. Nat Rev Rheumatol, 8(7):420-9.

**TABLE 87.2 Results of the Serological Testing for Alphavirus Infections Performed in Our Case**

| Virus         | IgM-IFA (29 August) | IgG-IFA (29 August) | PRNT (29 August) | IgM-IFA (12 September) | IgG-IFA (12 September) | PRNT (12 September) | Interpretation of test result |
| :------------ | :------------------ | :------------------ | :--------------- | :--------------------- | :--------------------- | :------------------ | :---------------------------- |
| Mayaro        | 1280                | 2560                | 40               | 2560                   | 160                    | 40                  | positive                      |
| Sindbis       | <20                 | 160                 | <20              | <20                    | 160                    | <20                 | negative                      |
| Chikungunya   | <20                 | 160                 | n.d.             | <20                    | 160                    | n.d.                | negative                      |
| Ross River    | <20                 | 160                 | n.d.             | <20                    | 160                    | n.d.                | negative                      |
| Barmah Forest | <20                 | 20                  | n.d.             | <20                    | 20                     | n.d.                | negative                      |

IFA: indirect immunofluorescence assay (screening assay)
PRNT: plaque reduction neutralization test (confirmatory assay)
n.d.: not done (screening assay negative [and epidemiologically not supported])